Shams Tabrez
Impact in
- Molecular Medicine top 2%
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
Papers in
- Pharmacology 30
- Cholinesterase and Neurodegenerative Diseases 16
- Co-authors
- Nasimudeen R. Jabir (65 shared papers)Masood Ahmad (16 shared papers)Mohammad Amjad Kamal (45 shared papers)Torki A. Zughaibi (45 shared papers)Shazi Shakil (37 shared papers)Mohd Shahnawaz Khan (44 shared papers)Samina Wasi (8 shared papers)Mohd Suhail (26 shared papers)
- Journals
- CNS & Neurological Disorders - Drug Targets (13 papers)Saudi Journal of Biological Sciences (9 papers)Current Pharmaceutical Design (9 papers)Journal of Cellular Biochemistry (8 papers)Journal of Biomolecular Structure and Dynamics (5 papers)
- Partner nations
- Saudi ArabiaIndiaUnited States
In The Last Decade
Shams Tabrez
224 papers receiving 6.3k citations
Shams Tabrez's Hit Papers
Peers
Comparison fields: 5 of 162
- Molecular Medicine 254
- Clinical Biochemistry 325
- Complementary and alternative medicine 371
- Biochemistry 252
- Pharmacology 603
Countries citing papers authored by Shams Tabrez
This map shows the geographic impact of Shams Tabrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shams Tabrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shams Tabrez more than expected).
Fields of papers citing papers by Shams Tabrez
This network shows the impact of papers produced by Shams Tabrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shams Tabrez. The network helps show where Shams Tabrez may publish in the future.
Co-authors
The 25 scholars most cited alongside Shams Tabrez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 232 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 302 | |
| 2 | 2012 | 260 | |
| 3 | 2014 | 173 | |
| 4 | 2012 | 153 | |
| 5 | 2018 | 149 | |
| 6 | 2013 | 138 | |
| 7 | 2015 | 131 | |
| 8 | 2012 | 128 | |
| 9 | 2018 | 94 | |
| 10 | 2021 | 88 | |
| 11 | 2022 | 87 | |
| 12 | 2022 | 82 | |
| 13 | 2021 | 81 | |
| 14 | 2023 | 80 | |
| 15 | 2016 | 75 | |
| 16 | 2009 | 72 | |
| 17 | 2022 | 70 | |
| 18 | 2014 | 69 | |
| 19 | 2022 | 68 | |
| 20 | 2021 | 66 |
About Shams Tabrez
Shams Tabrez is a scholar working on Molecular Biology, Pharmacology, Epidemiology, Physiology and Organic Chemistry, having authored 232 papers that have together received 6.5k indexed citations. Recurring topics across this work include Research on Leishmaniasis Studies (17 papers), Computational Drug Discovery Methods (16 papers), Cholinesterase and Neurodegenerative Diseases (16 papers), Advanced Glycation End Products research (12 papers), Alzheimer's disease research and treatments (12 papers), Carcinogens and Genotoxicity Assessment (11 papers), Natural Antidiabetic Agents Studies (10 papers) and Synthesis and biological activity (10 papers). The work is most often cited by research in Molecular Medicine (254 citations), Clinical Biochemistry (325 citations), Complementary and alternative medicine (371 citations), Biochemistry (252 citations) and Pharmacology (603 citations). Shams Tabrez has collaborated with scholars based in Saudi Arabia, India and United States. Frequent co-authors include Nasimudeen R. Jabir, Masood Ahmad, Mohammad Amjad Kamal, Torki A. Zughaibi, Shazi Shakil, Mohd Shahnawaz Khan, Samina Wasi, Mohd Suhail, Syed Kashif Zaidi and Adel Abuzenadah. Their work appears in journals such as CNS & Neurological Disorders - Drug Targets, Saudi Journal of Biological Sciences, Current Pharmaceutical Design, Journal of Cellular Biochemistry and Journal of Biomolecular Structure and Dynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.